Sign in Subscribe
Vaccines

US Government Terminates 22 Federal Contracts for mRNA-Based Vaccines, Shifting Focus to "Safer, Broader Vaccine Platforms"

Strategic Insights

— 1 min read

The US government has announced the termination of 22 federal contracts for mRNA-based vaccines, citing concerns over the technology's safety and effectiveness in protecting against upper respiratory infections like COVID and flu. This move marks the latest effort by Health Secretary Robert F. Kennedy Jr. to inject vaccine skepticism into US government policy. The affected projects, worth nearly $500 million, include Moderna's mRNA bird flu vaccine and initiatives from pharmaceutical giants Pfizer and Sanofi. In a statement, Secretary Kennedy emphasized that the Department of Health and Human Services supports safe and effective vaccines, but is shifting funding towards "better solutions." This decision has significant implications for the future of vaccine development and public health policy in the US.

Key Takeaways:

  • The US government has terminated 22 federal contracts for mRNA-based vaccines, worth nearly $500 million, due to concerns over the technology's safety and effectiveness.
  • The affected projects include Moderna's mRNA bird flu vaccine and initiatives from pharmaceutical giants Pfizer and Sanofi.
  • Health Secretary Robert F. Kennedy Jr. has been instrumental in injecting vaccine skepticism into US government policy, overseeing a major overhaul of US health policy since taking office.
  • Secretary Kennedy has ordered a sweeping new study on the long-debunked link between vaccines and autism, despite its strong safety record.
  • The mRNA technology, developed through President Trump's Operation Warp Speed, was credited with helping end the COVID pandemic and saving millions of lives.
  • The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing to the unprecedented rate of vaccine development.

Statistics:

  • 22 federal contracts for mRNA-based vaccines terminated by the US government.
  • $500 million: worth of affected projects, including Moderna's mRNA bird flu vaccine initiatives from pharmaceutical giants Pfizer and Sanofi.
  • "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate."
  • 2023: Year in which Katalin Kariko and Drew Weissman were awarded the Nobel Prize in Medicine for their work on mRNA technology.

Sources:

  • BSS (2023): News release from the official news agency of Bangladesh, stating that the US government has terminated 22 federal contracts for mRNA-based vaccines.
  • Department of Health and Human Services (HHS): Press release citing that the affected projects are worth "nearly $500 million."
  • Robert F. Kennedy Jr.: Statement from the Health Secretary emphasizing that HHS supports safe and effective vaccines.

Read more